Antiplatelet properties of Pim kinase inhibition are mediated through disruption of thromboxane A2 receptor signaling.
Unsworth AJ, Bye AP, Sage T, Gaspar RS, Eaton N, Drew C, Stainer A, Kriek N, Volberding PJ, Hutchinson JL, Riley R, Jones S, Mundell SJ, Cui W, Falet H, Gibbins JM.
Unsworth AJ, et al.
Haematologica. 2021 Jul 1;106(7):1968-1978. doi: 10.3324/haematol.2019.223529.
Haematologica. 2021.
PMID: 32467143
Free PMC article.